View more on these topics

SYZ & Co – Oysetr Oncology Fund


Oyster Oncology Fund

Type: Sicav

Aim: Growth by investing in companies involved with the study and treatment of cancer

Minimum investment: One share

Investment split: 46.76% medical-biomedical, 27.42% medical – drugs, 8.95% therapeutics, 4.35% diagnostic equipment, 4.03% medical – generic drugs, 2.57% medical products, 2.28% medical instruments, 2.18% diversified manufacturing, 1.46% other

Place of registration: Luxemburg

Charges: up to 5% annual 1.75%, performance fee 10%

Commission: Subject to negotiation

Tel: 0041 433443780


Terms of delivery

The Government has set out six delivery models for personal accounts

A matter of trust

Do solicitors and accountants deserve the professional respectability they command?

UnumProv extends protection to 70

Unum Provident is extending its income protection plan to cover policyholders up to the age of 70 in response to the recent changes to age discrimination laws and the likely raising of the state pension age.The insurer believes it is unique in offering IP up to age 70- IP policies typically expire at age 65- […]

Bankhall offers 40% discount on Selector

Bankhall is offering its member firms 40 per cent discount on Old Broad Street Research’s Selector internet-based investment fund research service.


News and expert analysis straight to your inbox

Sign up


    Leave a comment


    Why register with Money Marketing ?

    Providing trusted insight for professional advisers. Since 1985 Money Marketing has helped promote and analyse the financial adviser community in the UK and continues to be the trusted industry brand for independent insight and thought leadership.

    News & analysis delivered directly to your inbox
    Register today to receive our range of news alerts including daily and weekly briefings

    Money Marketing Events
    Be the first to hear about our industry leading conferences, awards, roundtables and more.

    Research and insight
    Take part in and see the results of Money Marketing's flagship investigations into industry trends.

    Have your say
    Only registered users can post comments. As the voice of the adviser community, our content generates robust debate. Sign up today and make your voice heard.

    Register now

    Having problems?

    Contact us on +44 (0)20 7292 3712

    Lines are open Monday to Friday 9:00am -5.00pm